Imipramine N-oxide hydrate
CAS: 6829-98-7
Ref. 3D-FI24562
1mg | 136,00 € | ||
2mg | 188,00 € | ||
5mg | 325,00 € | ||
10mg | 452,00 € | ||
25mg | 905,00 € |
Informação sobre produto
- 10,11-Dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine N-Oxide hydrate
- 10,11-Dihydro-N,N-dimethyl-5H-dibenz(b,f)azepine-5-propanamine N-oxide
- 5-(3-(Dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine 5-oxide
- 5-(3-(Dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine N-oxide
- 5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)propyl)-10,11-dihydro-, N-oxide
- 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-, N-oxide
- Elepsin
- Imipramine N-oxide
- Imipramine oxide
- Imipraminoxide [INN]
- Ver mais sinónimos
- Imipraminoxido
- Imipraminoxido [INN-Spanish]
- Imipraminoxidum
- Imipraminoxidum [INN-Latin]
- N,N-dimethyl-3-(5-oxido-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propan-1-amine
- Unii-8Mks280Xjw
- [3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]dimethylamine oxide
- Imipraminoxide
Imipramine N-oxide hydrate is a polymer drug that belongs to the group of amines. It inhibits the activity of CYP450 enzymes and has been shown to be effective in treating inflammatory bowel disease (IBD). Imipramine N-oxide hydrate prevents adenosine A3 receptor activation and suppresses the production of dinucleotide phosphate, which may be responsible for its effectiveness in treating IBD. Imipramine N-oxide hydrate also has an effect on liver cells, which may lead to its effectiveness in treating infectious diseases. The drug is not active against autoimmune diseases, but it may have an effect on toll-like receptors.
Propriedades químicas
Consulta técnica sobre: 3D-FI24562 Imipramine N-oxide hydrate
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.